EUVIMEDEUVIMED entdecken
Crossref

TWEAK signaling drives the transition from psoriasis to atopic dermatitis–like inflammation in paradoxical eczema

Sahiti Marella iD, Rachael Bogle iD, Haihan Zhang iD, Jennifer Fox iD, Joseph Kirma iD, Xianying Xing iD, Benjamin Klein iD, Vincent van Drongelen iD, Zoey Feister iD, Fadia Zagairy, Mira Hamed iD, Maya Liaks iD und 8 weitere

Science Translational Medicine · 04.11.2026 · 18 (874)

DOI: 10.1126/scitranslmed.aeb7924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 04.11.2026. Verfasst von Sahiti Marella und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Psoriasis, Signal Transduction, Cytokine TWEAK. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Institutes of Health, Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted biologics have transformed the treatment of inflammatory skin diseases such as plaque psoriasis. However, some patients with psoriasis paradoxically develop eczematous skin reactions after therapy targeting tumor necrosis factor (TNF), interleukin-17 (IL-17), or IL-23. Although paradoxical eczema (PE) resembles atopic dermatitis (AD) clinically and histologically, the molecular mechanisms that drive its development remain poorly understood. Here, we generated high-resolution cellular and spatial maps of human skin using single-cell RNA sequencing, spatial transcriptomics, immunohistochemistry, and in vitro assays, profiling lesional biopsies from patients with PE ( n = 8 donors), alongside healthy control, psoriasis, and AD skin ( n = 4 donors per group). In PE, we identified distinct transcriptional changes characterized by myeloid and T cell expansion and an altered keratinocyte phenotype shaped by TNF-like weak inducer of apoptosis (TWEAK; encoded by TNFSF12 ) signaling through its receptor TNFRSF12A , confirmed at the protein level by immunohistochemistry. To define the underlying mechanism, we stimulated immortalized (N-TERT) and primary human keratinocytes and found that TWEAK acted together with IL-13 to drive a T helper 2– and type I interferon–polarized epithelial program that partially recapitulated the keratinocyte signature of PE lesions. We validated key target genes by quantitative polymerase chain reaction in primary keratinocytes. In THP-1 cells and primary human CD14 + monocytes, anti-TNF treatment induced TWEAK expression, suggesting a compensatory inflammatory circuit. Together, these findings identify the TWEAK–IL-13 axis as a key driver of PE and suggest how cytokine blockade may reshape cutaneous immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPsoriasisSignal TransductionCytokine TWEAKInflammationEczemaHumansKeratinocytesSkinInterleukin-13

Substanzen

Cytokine TWEAKTNFSF12 protein, humanInterleukin-13

Autor:innen und Institutionen

  • Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
  • Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Chemistry, University of Michigan, Ann Arbor, MI, USA.
  • Department of Dermatology, Rappaport Faculty of Medicine, Emek Medical Center, Technion, Israel.
  • A. Alfred Taubman Medical Research Institute, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Sahiti Marella, Rachael Bogle, Haihan Zhang, Jennifer Fox, Joseph Kirma, Xianying Xing, Benjamin Klein, Vincent van Drongelen, Zoey Feister, Mira Hamed, Maya Liaks, Rundong Jiang, Poulami Dey, Joanne Michelle Kahlenberg, Allison C Billi, Lam C Tsoi, Johann E Gudjonsson, Eran Cohen Barak

Förderung

  • National Institutes of Health
  • Israel Science Foundation

Zitieren

APA

Marella, S., Bogle, R., Zhang, H., Fox, J., Kirma, J., Xing, X., Klein, B., van Drongelen, V., Feister, Z., Zagairy, F., Hamed, M., Liaks, M., Ziv, M., Jiang, R., Dey, P., Kahlenberg, J. M., Billi, A. C., Tsoi, L. C., Gudjonsson, J. E., & Barak, E. C. (2026). TWEAK signaling drives the transition from psoriasis to atopic dermatitis–like inflammation in paradoxical eczema. Science Translational Medicine, 18(874). https://doi.org/10.1126/scitranslmed.aeb7924

Vancouver

Marella S, Bogle R, Zhang H, Fox J, Kirma J, Xing X, et al. TWEAK signaling drives the transition from psoriasis to atopic dermatitis–like inflammation in paradoxical eczema. Science Translational Medicine. 2026;18(874). doi:10.1126/scitranslmed.aeb7924

BibTeX
@article{Marella2026,
  author = {Marella, Sahiti and Bogle, Rachael and Zhang, Haihan and Fox, Jennifer and Kirma, Joseph and Xing, Xianying and Klein, Benjamin and van Drongelen, Vincent and Feister, Zoey and Zagairy, Fadia and Hamed, Mira and Liaks, Maya and Ziv, Michael and Jiang, Rundong and Dey, Poulami and Kahlenberg, Joanne Michelle and Billi, Allison C and Tsoi, Lam C and Gudjonsson, Johann E and Barak, Eran Cohen},
  title = {TWEAK signaling drives the transition from psoriasis to atopic dermatitis–like inflammation in paradoxical eczema},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {874},
  doi = {10.1126/scitranslmed.aeb7924}
}
Kostenlos starten →